Kuros Biosciences AG (FRA:YTSN)

Kuros Biosciences AG Revenue

Kuros Biosciences AG had revenue of 63.48M CHF in the half year ending June 30, 2025, with 393.39% growth. This brings the company's revenue in the last twelve months to 103.35M, up 129.81% year-over-year. In the year 2024, Kuros Biosciences AG had annual revenue of 75.56M with 125.11% growth.

• Revenue (ttm): 103.35M CHF
• Revenue Growth: +129.81%
• P/S Ratio: 9.90
• Revenue / Employee: 654.12K CHF
• Employees: 158
• Market Cap: 1.10B EUR

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	75.56M	41.99M	125.11%
Dec 31, 2023	33.56M	15.58M	86.61%
Dec 31, 2022	17.99M	4.17M	30.19%
Dec 31, 2021	13.82M	9.78M	242.04%
Dec 31, 2020	4.04M	1.48M	57.71%